サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494295

欧州の凝固市場予測（～2030年）：地域別分析 - 症状別、タイプ別、提供別、技術別、エンドユーザー別

Europe Coagulation Market Forecast to 2030 - Regional Analysis - by Disease Indications, Type, Offering, Technology, and End User

出版日
ページ情報
英文 116 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
欧州の凝固市場予測（～2030年）：地域別分析 - 症状別、タイプ別、提供別、技術別、エンドユーザー別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 116 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の凝固の市場規模は、2022年に20億64万米ドルに達し、2022年～2030年にCAGR6.8%で成長し、2030年には33億7,971万米ドルに達すると予測されています。

心血管疾患の有病率の上昇が欧州の凝固市場を牽引

心疾患は、心房細動や脳卒中などによる入院、死亡、身体能力の低下の主な原因の1つです。心臓病は止血系、血管系、血液の流体力学に影響を及ぼし、動脈・静脈血栓症を引き起こします。血栓症は心血管系疾患による死亡・合併症の主な原因です。喫煙や高血圧によって損傷を受けた血管は、血管を覆うコレステロールを多く含むプラークを形成し、これが破裂して血小板が凝固することがあります。凝固障害では、心筋梗塞、脳卒中、血管床でのアテローム血栓性イベントのリスクがあります。心不全（HF）は心房細動（AF）の有無とは無関係に血栓塞栓症のリスク上昇に関係します。血小板の活性化や凝固系の異常は心不全患者における重篤な血栓塞栓症のリスクを増大させます。

凝固検査は心臓発作を引き起こす可能性のある血液凝固を予防するのに役立ちます。凝固分析装置は冠動脈バイパス術や血管形成術の際に血液凝固状態に関する情報をモニターするために使用されます。このように、心血管疾患の罹患率の増加が凝固市場の成長を後押ししています。

欧州の凝固市場概要

欧州の凝固市場は、ドイツ、フランス、英国、イタリア、スペイン、その他欧州に区分されます。欧州は世界の凝固市場で重要な位置を占めており、2022～2030年の間に堅調なCAGRを記録すると推定されています。同地域の市場成長の主な要因は、心血管障害の罹患率の上昇、医療機器の進歩の増加、高齢化人口の増加、凝固分析装置の認知度の急上昇などです。

ドイツでは多くの人々が心血管障害に苦しんでおり、これは同国における高齢化人口の増加に起因しています。心臓発作は冠動脈性心疾患（CHD）の最も深刻な結果です。現在までに、ドイツの人口のうち360万人以上がCHDと診断され、130万人以上が脳卒中から生還しています。2020年に発表されたWHOの最新データによると、ドイツにおけるCHDによる死亡者数は14万7,055人（全死亡者数の20.98％）に達しました。

欧州の凝固市場の収益と2030年までの予測（金額）

欧州の凝固市場セグメンテーション

欧州の凝固市場は、症状、タイプ、提供、技術、エンドユーザー、国によって区分されます。

症状別に見ると、欧州の凝固市場はビタミンK欠乏症、肝疾患、播種性血管内凝固・肺塞栓症、循環性抗凝固薬の開発、血友病、フォンウィルブランド病、その他に区分されます。肝疾患セグメントが2022年の欧州の凝固市場シェアで最大を占めました。

タイプ別に見ると、欧州の凝固市場は臨床検査分析装置とポイントオブケア検査分析装置に二分されます。2022年の欧州の凝固市場シェアは、臨床検査分析装置セグメントが大きくなっています。臨床検査分析装置セグメントはさらに、コントロール・キャリブレーター、アッセイ・試薬、機器／システム、凝固因子、その他に細分化されます。

提供別では、欧州の凝固市場は診断と治療に二分されます。診断セグメントは2022年の欧州の凝固市場においてより大きなシェアを占めています。診断セグメントはさらにプロトロンビン時間検査、フィブリノゲン検査、活性化凝固時間検査、活性化部分トロンボプラスチン時間検査、dダイマー検査、血小板機能検査、その他の活動に細分化されます。治療セグメントはさらに、抗線溶薬、避妊薬、デスモプレシン・免疫抑制薬、ビタミンkサプリメント、血液希釈薬、トロンビン阻害薬または血栓溶解薬、補充療法、カテーテル補助血栓除去、その他に細分化されます。

技術別では、欧州の凝固市場は光学技術、機械技術、電気化学技術、その他に区分されます。2022年の欧州の凝固市場シェアは、光学技術分野が最大でした。

エンドユーザー別では、欧州の凝固市場は臨床検査室、病院、その他に区分されます。病院セグメントは2022年に欧州の凝固市場最大のシェアを占めました。

国別では、欧州の凝固市場はドイツ、フランス、英国、イタリア、スペイン、その他欧州に分類されます。2022年にはドイツが欧州の凝固市場を独占しました。

F.ホフマン・ラ・ロシュ社、Genrui Biotech社、堀場製作所、ImproGen Diagnostik Kimya San.Ltd.Sti.、Siemens Healthineers AG、Sysmex Corp、Transasia Bio-Medicals Ltd、Nordic Biomarker ABなどが欧州の凝固市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の凝固市場- 主要産業力学

  • 主な市場促進要因
    • 血液疾患の有病率の増加
    • 心血管疾患の有病率の上昇
  • 市場抑制要因
    • 凝固分析装置に関連する高コスト
  • 市場機会
    • 主要市場企業による有機的・無機的戦略の成長
  • 今後の動向
    • ポイントオブケア（POC）凝固分析装置の発展
  • 影響分析

第5章 凝固市場：欧州市場分析

  • 欧州の凝固市場収益（2022年～2030年）

第6章 欧州の凝固市場 - 2030年までの収益と予測：症状別

  • 欧州の凝固市場の収益シェア：症状別（2022年・2030年）
  • ビタミンK欠乏症
  • 肝疾患
  • 播種性血管内凝固症候群と肺塞栓症
  • 循環型抗凝固薬の開発
  • 血友病
  • フォンウィルブランド病
  • その他

第7章 欧州の凝固市場 - 2030年までの収益と予測：タイプ別

  • 欧州の凝固市場の収益シェア：タイプ別（2022年・2030年）
  • 臨床検査分析装置
  • ポイントオブケア検査分析装置

第8章 欧州の凝固市場 - 2030年までの収益と予測：提供別

  • 欧州の凝固市場の収益シェア：提供別（2022年・2030年）
  • 診断
  • 治療

第9章 欧州の凝固市場 - 2030年までの収益と予測：技術別

  • 欧州の凝固市場の収益シェア：技術別（2022年・2030年）
  • 光学技術
  • 機械技術
  • 電気化学技術
  • その他

第10章 欧州の凝固市場 - 2030年までの収益と予測：エンドユーザー別

  • 欧州の凝固市場の収益シェア：エンドユーザー別（2022年・2030年）
  • 臨床検査室
  • 病院
  • その他

第11章 欧州の凝固市場：国別分析

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第12章 欧州の凝固市場-業界情勢

  • 凝固市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 企業プロファイル

  • Siemens Healthineers AG
  • ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
  • Nordic Biomarker AB
  • Sysmex Corp
  • F. Hoffmann-La Roche Ltd
  • Genrui Biotech Co., Ltd.
  • Transasia Bio-Medicals Ltd
  • Horiba Ltd.

第14章 付録

図表

List Of Tables

  • Table 1. Europe Coagulation Market Segmentation
  • Table 2. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 3. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 4. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 5. Optical Technologies and Their Applications
  • Table 6. Mechanical Technologies and Their Applications
  • Table 7. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 8. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 9. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 10. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 11. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 12. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 13. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 14. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 15. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 16. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 17. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 18. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 19. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 20. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 21. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 22. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 23. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 24. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 25. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 26. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 27. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 28. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 29. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 30. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 31. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 32. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 34. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 35. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 36. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 37. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 38. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 39. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 40. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 41. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 42. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 43. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 44. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 45. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 46. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 47. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 48. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 49. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 50. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 51. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 52. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 53. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 54. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 55. Recent Inorganic Growth Strategies in the Coagulation Market
  • Table 56. Recent Organic Growth Strategies in the Coagulation Market
  • Table 57. Glossary of Terms, Coagulation Market

List Of Figures

  • Figure 1. Europe Coagulation Market Segmentation, By Country
  • Figure 2. Europe Coagulation Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Coagulation Market Revenue (US$ million), 2020 - 2030
  • Figure 5. Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 6. Vitamin K Deficiency: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Liver Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Development of Circulating Anticoagulant: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Hemophilia: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Von Willebrand's Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 14. Clinical Laboratory Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Point-of-Care Testing Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
  • Figure 17. Diagnosis: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Treatment: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 20. Optical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Mechanical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Electrochemical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 25. Clinical Laboratories: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Hospitals: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Europe Coagulation Market, By Geography, 2022 ($million)
  • Figure 29. Europe Coagulation Market, By Key Countries, 2022 and 2030 (%)
  • Figure 30. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 31. UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 32. France Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 34. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 35. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 36. Growth Strategies in the Coagulation Market
目次
Product Code: BMIRE00029855

The Europe coagulation market was valued at US$ 2,000.64 million in 2022 and is expected to reach US$ 3,379.71 million by 2030; it is estimated to grow at a CAGR of 6.8% from 2022 to 2030.

Rising Prevalence of Cardiovascular Diseases Fuel Europe Coagulation Market

Heart disease is one of the leading causes of hospitalization, death, and reduced physical performance due to conditions such as atrial fibrillation and stroke. It affects the hemostatic system, vascular system, and fluid dynamics of blood and causes arterial and venous thrombosis. Thrombosis is the leading cause of death and complications from cardiovascular disease. Blood vessels damaged by smoking and high blood pressure form cholesterol-rich plaques lining the blood vessels, which can rupture and cause platelets to clot. With coagulation disorders, there is a risk of myocardial infarction, stroke, and atherothrombotic events in the vascular beds. Heart failure (HF) is related to an increased risk of thromboembolism independent of the presence of atrial fibrillation (AF). Platelet activation and coagulation system abnormalities can increase the risk of serious thromboembolic events in patients suffering from HF.

A coagulation test helps prevent potential heart attack-causing blood clotting. A coagulation analyzer is used during coronary artery bypass surgery and angioplasty to monitor information on blood clotting status. Thus, the growing incidence of cardiovascular diseases bolsters the coagulation market growth.

Europe Coagulation Market Overview

The Europe coagulation market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe holds a significant position in the global coagulation market and is estimated to register a robust CAGR during 2022-2030. Market growth in this region is mainly attributed to the rising incidence of cardiovascular disorders, increasing advancements in medical devices, the growing aging population, and the surging awareness of coagulation analyzers.

A large number of people in Germany are suffering from cardiovascular disorders, which can be attributed to the growing aging population in the country. Heart attack is the most serious consequence of coronary heart disease (CHD). More than 3.6 million of the German population have been diagnosed with CHD till date, and over 1.3 million have survived a stroke. According to the latest WHO data published in 2020, the count of deaths caused by CHD in Germany reached 147,055 (i.e., 20.98% of total deaths).

Europe Coagulation Market Revenue and Forecast to 2030 (US$ Million)

Europe Coagulation Market Segmentation

The Europe coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the Europe coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest Europe coagulation market share in 2022.

Based on type, the Europe coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger Europe coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the Europe coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger Europe coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the Europe coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest Europe coagulation market share in 2022.

By end user, the Europe coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest Europe coagulation market share in 2022.

Based on country, the Europe coagulation market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe coagulation market in 2022.

F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.; Siemens Healthineers AG; Sysmex Corp; Transasia Bio-Medicals Ltd; and Nordic Biomarker AB are some of the leading companies operating in the Europe coagulation market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Coagulation Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Blood Disorders
    • 4.1.2 Rising Prevalence of Cardiovascular Diseases
  • 4.2 Market Restraints
    • 4.2.1 High Costs Associated with Coagulation Analyzers
  • 4.3 Market Opportunities
    • 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
  • 4.4 Future Trends
    • 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
  • 4.5 Impact Analysis

5. Coagulation Market - Europe Market Analysis

  • 5.1 Europe Coagulation Market Revenue (US$ million), 2022 - 2030

6. Europe Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

  • 6.1 Overview
  • 6.2 Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 6.3 Vitamin K Deficiency
    • 6.3.1 Overview
    • 6.3.2 Vitamin K Deficiency: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Liver Disease
    • 6.4.1 Overview
    • 6.4.2 Liver Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
    • 6.5.1 Overview
    • 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Development of Circulating Anticoagulant
    • 6.6.1 Overview
    • 6.6.2 Development of Circulating Anticoagulant: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hemophilia
    • 6.7.1 Overview
    • 6.7.2 Hemophilia: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Von Willebrand's Disease
    • 6.8.1 Overview
    • 6.8.2 Von Willebrand's Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Others
    • 6.9.1 Overview
    • 6.9.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Coagulation Market - Revenue and Forecast to 2030 - by Type

  • 7.1 Overview
  • 7.2 Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
  • 7.3 Clinical Laboratory Analyzers
    • 7.3.1 Overview
    • 7.3.2 Clinical Laboratory Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
  • 7.4 Point-of-Care Testing Analyzers
    • 7.4.1 Overview
    • 7.4.2 Point-of-Care Testing Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Coagulation Market - Revenue and Forecast to 2030 - by Offering

  • 8.1 Overview
  • 8.2 Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
  • 8.3 Diagnosis
    • 8.3.1 Overview
    • 8.3.2 Diagnosis: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 Europe Coagulation Market, by Diagnosis
  • 8.4 Treatment
    • 8.4.1 Overview
    • 8.4.2 Treatment: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 Europe Coagulation Market, by Treatment

9. Europe Coagulation Market - Revenue and Forecast to 2030 - by Technology

  • 9.1 Overview
  • 9.2 Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
  • 9.3 Optical Technology
    • 9.3.1 Overview
    • 9.3.2 Optical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Mechanical Technology
    • 9.4.1 Overview
    • 9.4.2 Mechanical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Electrochemical Technology
    • 9.5.1 Overview
    • 9.5.2 Electrochemical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Coagulation Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Clinical Laboratories
    • 10.3.1 Overview
    • 10.3.2 Clinical Laboratories: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Hospitals
    • 10.4.1 Overview
    • 10.4.2 Hospitals: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Coagulation Market - Country Analysis

  • 11.1 Europe Coagulation Market, Revenue and Forecast to 2030
    • 11.1.1 Europe Coagulation Market by Country
      • 11.1.1.1 Germany
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.1.3 Germany Coagulation Market, by Disease Indication
        • 11.1.1.1.4 Germany Coagulation Market, by Type
        • 11.1.1.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
        • 11.1.1.1.5 Germany Coagulation Market, by Offering
        • 11.1.1.1.5.1 Germany Coagulation Market, by Diagnosis
        • 11.1.1.1.5.2 Germany Coagulation Market, by Treatment
        • 11.1.1.1.6 Germany Coagulation Market, by Technology
        • 11.1.1.1.7 Germany Coagulation Market, by End User
      • 11.1.1.2 UK
        • 11.1.1.2.1 Overview
        • 11.1.1.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.2.2 UK Coagulation Market, by Disease Indication
        • 11.1.1.2.3 UK Coagulation Market, by Type
        • 11.1.1.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
        • 11.1.1.2.4 UK Coagulation Market, by Offering
        • 11.1.1.2.4.1 UK Coagulation Market, by Diagnosis
        • 11.1.1.2.4.2 UK Coagulation Market, by Treatment
        • 11.1.1.2.5 UK Coagulation Market, by Technology
        • 11.1.1.2.6 UK Coagulation Market, by End User
      • 11.1.1.3 France
        • 11.1.1.3.1 Overview
        • 11.1.1.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.3.2 France Coagulation Market, by Disease Indication
        • 11.1.1.3.3 France Coagulation Market, by Type
        • 11.1.1.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
        • 11.1.1.3.4 France Coagulation Market, by Offering
        • 11.1.1.3.4.1 France Coagulation Market, by Diagnosis
        • 11.1.1.3.4.2 France Coagulation Market, by Treatment
        • 11.1.1.3.5 France Coagulation Market, by Technology
        • 11.1.1.3.6 France Coagulation Market, by End User
      • 11.1.1.4 Italy
        • 11.1.1.4.1 Overview
        • 11.1.1.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.4.2 Italy Coagulation Market, by Disease Indication
        • 11.1.1.4.3 Italy Coagulation Market, by Type
        • 11.1.1.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
        • 11.1.1.4.4 Italy Coagulation Market, by Offering
        • 11.1.1.4.4.1 Italy Coagulation Market, by Diagnosis
        • 11.1.1.4.4.2 Italy Coagulation Market, by Treatment
        • 11.1.1.4.5 Italy Coagulation Market, by Technology
        • 11.1.1.4.6 Italy Coagulation Market, by End User
      • 11.1.1.5 Spain
        • 11.1.1.5.1 Overview
        • 11.1.1.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.5.3 Spain Coagulation Market, by Disease Indication
        • 11.1.1.5.4 Spain Coagulation Market, by Type
        • 11.1.1.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
        • 11.1.1.5.5 Spain Coagulation Market, by Offering
        • 11.1.1.5.5.1 Spain Coagulation Market, by Diagnosis
        • 11.1.1.5.5.2 Spain Coagulation Market, by Treatment
        • 11.1.1.5.6 Spain Coagulation Market, by Technology
        • 11.1.1.5.7 Spain Coagulation Market, by End User
      • 11.1.1.6 Rest of Europe
        • 11.1.1.6.1 Overview
        • 11.1.1.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.6.3 Rest of Europe Coagulation Market, by Disease Indication
        • 11.1.1.6.4 Rest of Europe Coagulation Market, by Type
        • 11.1.1.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
        • 11.1.1.6.5 Rest of Europe Coagulation Market, by Offering
        • 11.1.1.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
        • 11.1.1.6.5.2 Rest of Europe Coagulation Market, by Treatment
        • 11.1.1.6.6 Rest of Europe Coagulation Market, by Technology
        • 11.1.1.6.7 Rest of Europe Coagulation Market, by End User

12. Europe Coagulation Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Coagulation Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Siemens Healthineers AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Nordic Biomarker AB
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sysmex Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 F. Hoffmann-La Roche Ltd
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Genrui Biotech Co., Ltd.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Transasia Bio-Medicals Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Horiba Ltd.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms